Spesolimab prevents generalized pustular psoriasis flares in EFFISAYIL™ 2 trial
Data demonstrate superiority vs. placebo in preventing generalized pustular psoriasis (GPP) flares up to 48 weeks1 Prevention of unpredictable flares addresses a high unmet patient need2,3 Results build on the EFFISAYIL™ 1 trial, which demonstrated rapid and s



